In ESCC, for instance, TAM-derived CCL22 can hyperactivate focal adhesion kinase (FAK) in ESCC cells by promoting the formation of a complex with diacylglycerol kinase alpha (DGKα). This evidence concerns the gene PTK2 and esophageal squamous cell carcinoma.